Monte Rosa Therapeutics Inc.

5.53
-0.16 (-2.81%)
At close: Jan 22, 2025, 3:59 PM
5.53
0.09%
After-hours Jan 22, 2025, 04:00 PM EST

Monte Rosa Therapeutics Inc. Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for GLUE stock have an median target of 11, with a low estimate of 11 and a high estimate of 16. The median target predicts an increase of 98.92% from the current stock price of 5.53.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $12.67 $11 $16
Change 98.92% 129.11% 98.92% 189.33%

AI Analyst Report

Wedbush maintains an Outperform rating for Monte R... Unlock content with Pro Subscription

Updated Sep 12, 2024

Rating Feb 24May 24Jun 24Aug 24Sep 24Dec 24
Strong Buy 000000
Buy 111110
Hold 000001
Sell 000000
Strong Sell 000000
Total 1 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
66.18M
from 0
Increased by -%
Revenue Next Year
24.18M
from 66.18M
Increased by -63.5%
EPS This Year
-1.01
from -2.63
Increased by 61.6%
EPS Next Year
-1.55
from -1.01
Increased by -53.5%